Optic pathway gliomas in adolescence-time to challenge treatment choices?

Neuro-Oncology

Volumn 15, Issue 3, 2013, Pages 391-400

  Chong, Amy Lee ^a,b   Pole, Jason D ^b   Scheinemann, Katrin ^c   Hukin, Juliette ^d   Tabori, Uri ^a   Huang, Annie ^a   Bouffet, Eric ^a   Bartels, Ute ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b PEDIATRIC ONCOLOGY GROUP OF ONTARIO   (Canada)

^c MCMASTER CHILDREN S HOSPITAL   (Canada)

^d BC CHILDREN S HOSPITAL   (Canada)

Author keywords

adolescents; chemotherapy; glioma; OPHG; optic pathway

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; GLIOMA; HOSPITALIZED ADOLESCENT; HUMAN; HUMAN TISSUE; HYPOTHALAMUS; HYPOTHALAMUS TUMOR; MALE; NEUROFIBROMATOSIS; OPTIC PATHWAY HYPOTHALAMIC GLIOMA; PEDIATRIC SURGERY; PRESCHOOL CHILD; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; SCHOOL CHILD; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC AGENTS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOTHALAMIC NEOPLASMS; INFANT; INFANT, NEWBORN; MALE; NEOPLASM GRADING; OPTIC NERVE GLIOMA; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84874550483     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos312     Document Type: Article

References (36)

1. Laithier V, Grill J, Le Deley MC, et al. Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy-results of the first French prospective study for the French Society of Pediatric Oncology. J Clin Oncol. 2003;21(24):4572-4578. (Pubitemid 46594029)
2. Liu GT, Brodsky MC, Phillips PC, et al. Optic radiation involvement in optic pathway gliomas in neurofibromatosis. Am J Ophthalmol. 2004;137(3):407-414. (Pubitemid 38328629)
3. Opocher E, Kremer LC, Da Dalt L, et al. Prognostic factors for progression of childhood optic pathway glioma: a systematic review. Eur J Cancer. 2006;42(12):1807-1816. (Pubitemid 44149098)
4. Astrup J. Natural history and clinical management of optic pathway glioma. Br J Neurosurg. 2003;17(4):327-335. (Pubitemid 37243963)
5. Khafaga Y, Hassounah M, Kandil A, et al. Optic gliomas: a retrospective analysis of 50 cases. Int J Radiat Oncol Biol Phys. 2003;56(3):807-812. (Pubitemid 36677376)
6. Gnekow AK, Kortmann RD, Pietsch T, Emser A. Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristin chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy-report from the multicenter treatment study for children and adolescents with a low grade glioma-HIT-LGG 1996-of the Society of Pediatric Oncology and Hematology (GPOH). Klin Padiatr. 2004;216(6):331-342. (Pubitemid 39524567)
7. Ater JL, Zhou T, Holmes E, et al. Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group. J Clin Oncol. 2012;30(21):2641-2647.
8. SIOP. SIOP CNS Germ Cell Tumour Studies 96. http://www.siop.nl/pagina- 214.html.
9. Taylor T, Jaspan T, Milano G, et al. Radiological classification of optic pathway gliomas: experience of a modified functional classification system. Br J Radiol. 2008;81(970):761-766.
10. Listernick R, Charrow J, Greenwald M, Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr. 1994;125(1):63-66. (Pubitemid 24225179)
11. Listernick R, Ferner RE, Piersall L, Sharif S, Gutmann DH, Charrow J. Late-onset optic pathway tumors in children with neurofibromatosis Neurology. 2004;63(10):1944-1946. (Pubitemid 39532398)
12. Thiagalingam S, Flaherty M, Billson F, North K. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients. Ophthalmology. 2004;111(3):568-577. (Pubitemid 38293118)
13. Cappelli C, Grill J, Raquin M, et al. Long-term follow up of 69 patients treated for optic pathway tumours before the chemotherapy era. Arch Dis Child. 1998;79(4):334-338. (Pubitemid 28436086)
14. Tow SL, Chandela S, Miller NR, Avellino AM. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol. 2003;28(4):262-270. (Pubitemid 36802224)
15. Bouffet E, Jakacki R, Goldman S, et al. Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. J Clin Oncol. 2012;30(12):1358-1363.
16. Schiavetti A, Varrasso G, Maurizi P, Castello MA. Hypersensitivity to carboplatin in children. Med Pediatr Oncol. 1999;32(3):183-185. (Pubitemid 29095977)
17. Lazzareschi I, Ruggiero A, Riccardi R, Attina G, Colosimo C, Lasorella A. Hypersensitivity reactions to carboplatin in children. J Neurooncol. 2002;58(1):33-37. (Pubitemid 34711968)
18. Lafay-Cousin L, Holm S, Qaddoumi I, et al. Weekly vinblastine in pediatric low-grade glioma patients with carboplatin allergic reaction. Cancer. 2005;103(12):2636-2642. (Pubitemid 40800545)
19. Moore BD, 3rd, Ater JL, Needle MN, Slopis J, Copeland DR. Neuropsychological profile of children with neurofibromatosis, brain tumor, or both. J Child Neurol. 1994;9(4):368-377.
20. Bartels U, Hawkins C, Jing M, et al. Vascularity and angiogenesis as predictors of growth in optic pathway/hypothalamic gliomas. J Neurosurg. 2006;104(5 suppl):314-320. (Pubitemid 44954827)
21. Pfister S, Janzarik WG, Remke M, et al. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest. 2008;118(5):1739-1749. (Pubitemid 351632377)
22. Hawkins C, Walker E, Mohamed N, et al. BRAF-KIAA1549 fusion predicts better clinical outcome in pediatric low-grade astrocytoma. Clin Cancer Res. 2011;17(14):4790-4798.
23. Tao ML, Barnes PD, Billett AL, et al. Childhood optic chiasm gliomas: radiographic response following radiotherapy and longterm clinical outcome. Int J Radiat Oncol Biol Phys. 1997;39(3):579-587. (Pubitemid 27441423)
24. Grabenbauer GG, Schuchardt U, Buchfelder M, et al. Radiation therapy of optico-hypothalamic gliomas (OHG)-radiographic response, vision and late toxicity. Radiother Oncol. 2000;54(3):239-245. (Pubitemid 30157834)
25. Fouladi M, Gilger E, Kocak M, et al. Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. J Clin Oncol. 2005;23(28):7152-7160.
26. Sharif S, Ferner R, Birch JM, et al. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J Clin Oncol. 2006;24(16):2570-2575. (Pubitemid 46630636)
27. Janss AJ, Grundy R, Cnaan A, et al. Optic pathway and hypothalamic/chiasmatic gliomas in children younger than age 5 years with a 6-year follow-up. Cancer. 1995;75(4):1051-1059.
28. Collet-Solberg PF, Sernyak H, Satin-Smith M, et al. Endocrine outcome in long-term survivors of low-grade hypothalamic/chiasmatic glioma. Clin Endocrinol (Oxf). 1997;47(1):79-85. (Pubitemid 27313992)
29. Bowers DC, Mulne AF, Reisch JS, et al. Nonperioperative strokes in children with central nervous system tumors. Cancer. 2002;94(4):1094-1101. (Pubitemid 34150865)
30. Bowers DC, Liu Y, LeisenringW, et al. Late-occurring stroke among longterm survivors of childhood leukemia and brain tumors: a report from the Childhood Cancer Survivor Study.JClinOncol. 2006;24(33):5277-5282. (Pubitemid 46631374)
31. Combs SE, Schulz-Ertner D, Moschos D, Thilmann C, Huber PE, Debus J. Fractionated stereotactic radiotherapy of optic pathway gliomas: tolerance and long-term outcome. Int J Radiat Oncol Biol Phys. 2005;62(3):814-819. (Pubitemid 40779774)
32. Packer RJ, Sutton LN, Bilaniuk LT, et al. Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neurol. 1988;23(1):79-85.
33. SilvaMM,GoldmanS, Keating G, Marymont MA,Kalapurakal J, Tomita T. Optic pathway hypothalamic gliomas in children under three years of age: the role of chemotherapy. Pediatr Neurosurg. 2000;33(3):151-158.
34. Hsu TR, Wong TT, Chang FC, et al. Responsiveness of progressive optic pathway tumors to cisplatin-based chemotherapy in children. Childs Nerv Syst. 2008;24(12):1457-1461.
35. Demaerel P, de Ruyter N, Casteels I, Renard M, Uyttebroeck A, van Gool S. Visual pathway glioma in children treated with chemotherapy. Eur J Paediatr Neurol. 2002;6(4):207-212.
36. Heath JA, Turner CD, Poussaint TY, Scott RM, Goumnerova L, Kieran MW. Chemotherapy for progressive low-grade gliomas in children older than ten years: the Dana-Farber experience. Pediatr Hematol Oncol. 2003;20(7):497-504. (Pubitemid 37248192)